Companies

Ovid Therapeutics Inc. (OVID) SEC filings

CIK 0001636651 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)7.3 M3920001.5 M
Net income (USD)-54.2 M122.8 M
Diluted EPS (USD/shares)-0.741.76

Latest filings

FiledFormDescriptionPeriod
2026-08-24144144
2026-08-14144144
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 9.012026-08-11
2026-07-29SCHEDULE 13GSCHEDULE 13G
2026-07-08442026-07-06
2026-07-08332026-07-06
2026-07-08SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-088-K8-K items 5.022026-07-05
2026-06-17442026-06-15
2026-06-17332026-06-15
2026-06-118-K8-K items 5.072026-06-11
2026-06-038-K8-K items 5.022026-05-29
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13GSCHEDULE 13G
2026-05-15SCHEDULE 13GSCHEDULE 13G
2026-05-15SCHEDULE 13GSCHEDULE 13G
2026-05-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-1210-Q10-Q2026-03-31

Forms on file (last 1,000): 4 157, 8-K 137, SC 13G/A 33, 10-Q 29, 3 21, SC 13G 17, SCHEDULE 13G/A 15, 424B5 12. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=OVID (0.002 USD), /gw/filings/filings?ticker=OVID&form=8-K, /gw/filings/facts?ticker=OVID&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange